Innerscope Hearing Technologies (Innerscope Hearing Technologies) ROCE % : 0.00% (As of Dec. 2020)

View and export this data going back to 2017. Start your Free Trial

What is Innerscope Hearing Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Innerscope Hearing Technologies's annualized ROCE % for the quarter that ended in Dec. 2020 was 0.00%.

Innerscope Hearing Technologies ROCE % Historical Data

The historical data trend for Innerscope Hearing Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innerscope Hearing Technologies ROCE % Chart

Innerscope Hearing Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

ROCE %

Get a 7-Day Free Trial

53.96

Innerscope Hearing Technologies Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

Innerscope Hearing Technologies ROCE % Calculation

Innerscope Hearing Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2020 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2020 )		(A: Dec. 2019 )		(A: Dec. 2020 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2020 )		(A: Dec. 2019 )		(A: Dec. 2020 )
	=	-3.242	/	( ( (3.175 - 8.036)	+	(1.683 - 10.419) )	/ 2 )
	=	-3.242	/	( (-4.861	+	-8.736)	/ 2 )
	=	-3.242	/	-6.7985
	=	47.69 %

Innerscope Hearing Technologies's ROCE % of for the quarter that ended in Dec. 2020 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2020 )		(Q: Sep. 2020 )		(Q: Dec. 2020 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2020 )		(Q: Sep. 2020 )		(Q: Dec. 2020 )
	=	-2.492	/	( ( (2.788 - 10.715)	+	(1.683 - 10.419) )	/ 2 )
	=	-2.492	/	( ( -7.927	+	-8.736 )	/ 2 )
	=	-2.492	/	-8.3315
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2020) EBIT data.

Innerscope Hearing Technologies (OTCPK:INND) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Innerscope Hearing Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Innerscope Hearing Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Innerscope Hearing Technologies (Innerscope Hearing Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Innerscope Hearing Technologies Inc (OTCPK:INND) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2151 Professional Drive, Second Floor, Roseville, CA, USA, 95661

Website

https://www.innd.com

Innerscope Hearing Technologies Inc is a manufacturer and a DTC distributor/retailer of FDA-registered hearing aids, personal sound amplifier products, hearing-related treatment therapies, doctor-formulated dietary hearing supplements, and proprietary CDB oil for treating tinnitus. It also owns and operates audiological and retail hearing device clinics and plans to continue to open and acquire additional clinics. The company operates retail hearing device clinics in California.